Simultaneous Response in Several Domains in Patients with Psoriatic Disease Treated with Etanercept as Monotherapy or in Combination with Conventional Synthetic Disease-modifying Antirheumatic Drugs

Behrens Frank; Meier Lothar; Prinz Joerg C.; Jobst Juergen; Lippe Ralph; Loeschmann Peter-Andreas; Lorenz Hanns-Martin

首页> 外文期刊>The Journal of rheumatology >Simultaneous Response in Several Domains in Patients with Psoriatic Disease Treated with Etanercept as Monotherapy or in Combination with Conventional Synthetic Disease-modifying Antirheumatic Drugs

【24h】

Simultaneous Response in Several Domains in Patients with Psoriatic Disease Treated with Etanercept as Monotherapy or in Combination with Conventional Synthetic Disease-modifying Antirheumatic Drugs

机译：用Etanercept作为单疗法或与常规的合成疾病改性抗胃酸药物治疗的患有人的人体疾病患者的几个域同时反应

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective. To evaluate patients with psoriatic arthritis (PsA) receiving etanercept (ETN) monotherapy or ETN plus conventional synthetic disease-modifying antirheumatic drugs (csDMARD) to determine the proportion achieving a clinically meaningful response in arthritis, psoriasis, and quality of life simultaneously.

机译：客观的。为了评估患有人的人体性关节炎（PSA）接受entanercept（ETN）单药治疗或ETN加常规的合成疾病修饰的抗漏毒药（CSDMARD）以确定同时性关节炎，牛皮癣和生活质量的临床有意义反应的比例。

著录项

来源
《The Journal of rheumatology》 |2018年第6期|共9页
作者
Behrens Frank; Meier Lothar; Prinz Joerg C.; Jobst Juergen; Lippe Ralph; Loeschmann Peter-Andreas; Lorenz Hanns-Martin;
展开▼
作者单位

Goethe Univ CIRI Rheumatol Theodor Stern Kai 7 D-60596 Frankfurt Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
PSORIATIC ARTHRITIS; DERMATOLOGY; QUALITY OF LIFE; MUSCULOSKELETAL DISEASE; ETANERCEPT;

机译：银屑病关节炎;皮肤科;生活质量;肌肉骨骼疾病;etanercept;

相似文献

外文文献
专利

1. Simultaneous Response in Several Domains in Patients with Psoriatic Disease Treated with Etanercept as Monotherapy or in Combination with Conventional Synthetic Disease-modifying Antirheumatic Drugs [J] . Behrens Frank, Meier Lothar, Prinz Joerg C., The Journal of rheumatology . 2018,第6期

机译：用Etanercept作为单疗法或与常规的合成疾病改性抗胃酸药物治疗的患有人的人体疾病患者的几个域同时反应
2. Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis [J] . Blanca Hernández-Cruz, Esther Márquez-Saavedra, Rafael Caliz-Caliz, Arthritis research & therapy. . 2016,第1期

机译：在类风湿性关节炎患者中，第一种TNF拮抗剂在单一疗法，第一种TNF拮抗剂加一种常规的合成疾病缓解性抗风湿药和第一种TNF拮抗剂加两种或更多种常规的改善疾病的抗风湿性药物的单一治疗中的比较疗效
3. Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting [J] . Philip J. Mease, Neil A. Accortt, Sabrina Rebello, Rheumatology international. . 2019,第9期

机译：肿瘤坏死因子抑制剂或常规合成疾病改性的抗逆素药物单疗法或在真实世界的环境中的常规合成疾病调制的抗逆肿瘤单疗法或联合治疗
4. Psoriatic arthritis Clinical improvement and correlation with hormone axes in etanercept-treated patients [C] . Fabiola Atzeni, Rainer H. Straub, Maurizio Cutolo, International Conference on the Neuroendocrine Immune Basis of the Rheumatic Diseases . 2010

机译：依托西普治疗患者患者临床改善及与激素轴相关性
5. Effective combination of syngeneic HCT with CRCL vaccination to treat BCR-ABL+ leukemia, and, CD4+CD25+FOXP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. [D] . Chen, Xinchun. 2006

机译：同基因HCT与CRCL疫苗的有效结合可治疗BCR-ABL +白血病，CD4 + CD25 + FOXP3 +调节性T细胞可抑制活动性疾病患者的结核分枝杆菌免疫力。
6. Comparative effectiveness of treatment with the first TNF antagonist in monotherapy the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis [O] . Blanca Hernández-Cruz, Esther Márquez-Saavedra, Rafael Caliz-Caliz, 2016

机译：在类风湿性关节炎患者中第一种TNF拮抗剂在单一疗法第一种TNF拮抗剂加一种常规的合成疾病缓解性抗风湿药和第一种TNF拮抗剂加两种或多种常规合成的疾病缓解性风湿性药物治疗中的比较疗效
7. Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration [O] . Kim Lauper, Dan C Nordström, Karel Pavelka, 2018

机译：与TNF抑制剂与TNF抑制剂为单药治疗的比较效果或与常规合成疾病改性抗逆素药物在使用至少一种生物学疾病调制的抗耳动药物之后的类风湿性关节炎：从泛欧洲托尔拉注册协作分析

Simultaneous Response in Several Domains in Patients with Psoriatic Disease Treated with Etanercept as Monotherapy or in Combination with Conventional Synthetic Disease-modifying Antirheumatic Drugs

摘要

著录项

相似文献

相关主题

期刊订阅